Budgeting
Plus-size fashion GLP 1 Matt Fowler KC | Reshetnikov_art | Shutterstock

Fashion brands could be stuck with US$5 billion in unsold plus-size clothes as GLP-1 drugs reshape Canadians’ shopping

Fashion retailers across North America could be sitting on billions in unsold clothing as retail forecasting firm Impact Analytics warns that GLP-1 weight-loss drugs are reshaping the size curve faster than brands can adjust their orders.

The fallout is already visible on shelves. H&M has quietly discontinued its 3XL and 4XL sizes. Mango cut its size 16 to 20 dress offerings from 6.6% of new inventory to just 0.5% in one year. And Torrid, a chain built entirely around plus-size fashion, closed 151 stores — a third of its brick and mortar locations — last year, with 30 more closures planned for the first half of 2026.

Advertisement

For the roughly three million Canadians now using GLP-1 medications — alongside the millions more who wear plus sizes and aren’t on the drugs — this isn’t just a fashion story. It’s a preview of where prices, selection and deals could be headed.

The best of Money.ca delivered weekly.

By signing up, you accept Money.ca Terms of Use, Subscription Agreement, and Privacy Policy.

Why are brands stuck with billions in unsold stock?

For decades, apparel companies planned inventory around a population that kept getting larger every year. That trend has reversed for the first time in 50 years, which points to GLP-1 adoption as the leading driver.

If current trends hold, the firm estimates more than 400 million apparel units a year could be misaligned with real demand by 2027 — representing close to US$5 billion in retail capital and lost margin. That mismatch cuts both ways: demand for extra-small and small sizes is climbing, while orders placed a year or two ago for larger sizes are landing on shelves at a rate that fewer shoppers are buying.

Must Read

Join 19,000+ readers and get Money.ca’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

What it means for your closet and your budget

For Canadians who wear plus-sized clothing, the most visible effect is shrinking selection, but it isn’t spread evenly across the market. Trend-led retailers are cutting fastest. Anthropologie’s plus-size dress offerings fell from 10.5% to 9% year-over-year, while budget-focused Walmart added inventory for larger sizes this season, bucking the trend.

The upside, at least in the near term: brands rarely destroy stock they can still sell, so keep an eye out for clearance racks and outlet channels over the next several months for the sizes and styles that missed their moment.

In the longer-term, plus-size shoppers are already voting with their wallets on the resale market. On the platform ThredUp, purchase volume for large, extra-large and plus-size women’s apparel grew 17.4% this year — more than double the 6.8% growth rate for small and medium sizes.

Finally, if you use a GLP-1 medication and expect your size to keep changing, budget for wardrobe turnover the same way you budget for the prescription itself.

The bottom line

None of this means plus-size shoppers are out of options. It means the easy years — when major retailers were expanding size ranges by default — are behind them, at least for now. The brands still investing in extended sizing, and the resale market picking up where retail leaves off, are the places to look for the better deals and the better selection next.

You May Also Like

The most expensive financial mistakes are often the ones you don't see coming. Join 19,000+ Canadians who get the money moves, risks and opportunities shaping their finances — delivered free each week. Subscribe now.

Share this:
David Saric Associate editor

Writer and editor based in Toronto with experience in personal finance, insurance, arts and culture and branded content.

more from David Saric

Explore the latest

Disclaimer

The content provided on Money.ca is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.